We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

130 hedge funds and large institutions have $1.47B invested in Ironwood Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

7% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 41

5% less funds holding

Funds holding: 137 → 130 (-7)

15% less capital invested

Capital invested by funds: $1.73B → $1.47B (-$265M)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

56% less call options, than puts

Call options by funds: $1.74M | Put options by funds: $3.98M

Holders
130
Holders Change
-7
Holders Change %
-5.11%
% of All Funds
3.63%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
15
Increased
44
Reduced
41
Closed
21
Calls
$1.74M
Puts
$3.98M
Net Calls
-$2.24M
Net Calls Change
-$3.19M

Top Buyers

Rank Fund Capital Flow
1
RCMC
Rubric Capital Management (Connecticut)
Connecticut
+$71.6M
2
BI
BVF Inc
California
+$30.1M
3
BM
Bridger Management
New York
+$24.9M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$7.95M
5
EAM
EverPoint Asset Management
Connecticut
+$5.01M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$59M
2
Deutsche Bank
Deutsche Bank
Germany
-$47.9M
3
O
OrbiMed
New York
-$13.1M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$12.2M
5
FAM
Fred Alger Management
New York
-$10.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CTC
126
Central Trust Company
Missouri
$10K – – –
NHFG
127
New Harbor Financial Group
Massachusetts
$6K – – –
TRCT
128
Tower Research Capital (TRC)
New York
$4K -$6.76K -725 -60%
NFG
129
Next Financial Group
Texas
$1K +$1.11K +119 New
Manulife (Manufacturers Life Insurance)
130
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$861 +$26.2K +2,804 +3%
FAM
131
Fred Alger Management
New York
– -$10.6M -1,045,915 Closed
TCM
132
Tekla Capital Management
Massachusetts
– -$9.26M -917,052 Closed
HCM
133
Highbridge Capital Management
New York
– -$5.14M -509,360 Closed
Janus Henderson Group
134
Janus Henderson Group
United Kingdom
– -$4.57M -452,526 Closed
GTC
135
Ghost Tree Capital
New York
– -$4.22M -417,900 Closed
PAM
136
Paradigm Asset Management
New York
– -$2.32M -229,845 Closed
Allianz Asset Management
137
Allianz Asset Management
Germany
– -$2.02M -199,846 Closed
Two Sigma Investments
138
Two Sigma Investments
New York
– -$1.54M -152,358 Closed
PVI
139
Pura Vida Investments
New York
– -$1.04M -119,400 Closed
TC
140
TFS Capital
Pennsylvania
– -$1.19M -117,474 Closed
SGAM
141
Smith Group Asset Management
Texas
– -$899K -88,994 Closed
DM
142
Deerfield Management
New York
– -$768K -76,058 Closed
JG
143
Jefferies Group
New York
– -$433K -42,865 Closed
CCIA
144
Campbell & Co Investment Adviser
Maryland
– -$422K -41,766 Closed
NI
145
Numeric Investors
Massachusetts
– -$294K -29,134 Closed
AQR Capital Management
146
AQR Capital Management
Connecticut
– -$294K -29,060 Closed
CC
147
Cannell & Co
New York
– -$190K -18,770 Closed
M&T Bank
148
M&T Bank
New York
– -$128K -12,684 Closed
SG Americas Securities
149
SG Americas Securities
New York
– -$101K -10,026 Closed
Invesco
150
Invesco
Georgia
– -$59K -5,812 Closed
3 4 5
6
7

IRWD Hedge Fund Activity: Q3 2015 in Review

130 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2015, worth a combined $1.47B — down 15% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of IRWD and 15 opened new positions — a net loss of 6 holders — while 41 trimmed existing stakes and 44 added.

The largest buyer was Rubric Capital Management (Connecticut), opening a new position worth an estimated $71.6M. The largest seller was Morgan Stanley, cutting an estimated $59M.

  • 130 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2015, down from 137 in Q2 2015.
  • Funds reported $1.47B of Ironwood Pharmaceuticals stock for Q3 2015, down 15% quarter-over-quarter.
  • 15 funds opened new Ironwood Pharmaceuticals positions in Q3 2015 and 21 closed out, a net change of -6 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2015 was Rubric Capital Management (Connecticut), an estimated $71.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2015 was Morgan Stanley, an estimated $59M sold.

Based on aggregated 13F filings for Q3 2015.